Filing Details

Accession Number:
0001179110-21-009815
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-03 16:02:09
Reporting Period:
2021-11-01
Accepted Time:
2021-11-03 16:02:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
744218 Celldex Therapeutics Inc. CLDX In Vitro & In Vivo Diagnostic Substances (2835) 133191702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718112 Margo Heath-Chiozzi C/O Celldex Therapeutics, Inc.
53 Frontage Road, Suite 220
Hampton NJ 08827
Svp Of Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-01 600 $2.78 11,847 No 4 M Direct
Common Stock Disposition 2021-11-01 600 $41.71 11,247 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (Right to Buy) Disposition 2021-11-01 600 $0.00 600 $2.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,400 2029-06-19 No 4 M Direct
Footnotes
  1. The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021.
  2. 25 % vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.